Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Transplantation

  Free Subscription


Articles published in J Hepatol

Retrieve available abstracts of 54 articles:
HTML format
Text format



Single Articles


    May 2017
  1. NADIM MK, DiNorcia J, Ji L, Groshen S, et al
    Inequity In Organ Allocation For Patients Awaiting Liver Transplantation: Rationale for Uncapping the Model for End-Stage Liver Disease.
    J Hepatol. 2017 May 5. pii: S0168-8278(17)32003.
    PubMed     Text format     Abstract available


    April 2017
  2. COLMENERO J, Sancho-Bru P
    Mesenchymal stromal cells for immunomodulatory cell therapy in liver transplantation: one step at a time.
    J Hepatol. 2017 Apr 20. pii: S0168-8278(17)30215.
    PubMed     Text format    


    March 2017
  3. BELLI LS, Duvoux C, Berg T, Strazzabosco M, et al
    ELITA consensus statements on use of DAAs in liver transplant candidates and recipients.
    J Hepatol. 2017 Mar 18. pii: S0168-8278(17)30140.
    PubMed     Text format     Abstract available


  4. DETRY O, Vandermeulen M, Delbouille MH, Somja J, et al
    Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study.
    J Hepatol. 2017 Mar 8. pii: S0168-8278(17)30131.
    PubMed     Text format     Abstract available


    November 2016
  5. NOTARPAOLO A, Layese R, Magistri P, Gambato M, et al
    Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    J Hepatol. 2016 Nov 26. pii: S0168-8278(16)30688.
    PubMed     Text format     Abstract available


    July 2016
  6. PAIS R, Sidney Barritt A 4th, Calmus Y, Scatton O, et al
    Nafld and liver transplantation: current burden and expected challenges.
    J Hepatol. 2016 Jul 30. pii: S0168-8278(16)30403.
    PubMed     Text format     Abstract available


  7. RUF AE, Dirchwolf M, Biggins SW, Villamil FG, et al
    Revising metrics for aggressiveness assessment in liver transplantation centers.
    J Hepatol. 2016 Jul 28. pii: S0168-8278(16)30350.
    PubMed     Text format    


  8. GOLDBERG DS, Abt PL
    Response to Revising Metrics for Aggressiveness Assessment in Liver Transplantation Centers.
    J Hepatol. 2016 Jul 28. pii: S0168-8278(16)30398.
    PubMed     Text format    


  9. YANG JD, Aqel BA, Pungpapong S, Gores GJ, et al
    Direct Acting Antiviral Therapy and Tumor Recurrence after Liver Transplant for Hepatitis C-Associated Hepatocellular Carcinoma.
    J Hepatol. 2016 Jul 5. pii: S0168-8278(16)30318.
    PubMed     Text format    


    June 2016
  10. COILLY A, Fougerou-Leurent C, de Ledinghen V, Houssel-Debry P, et al
    Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence after liver transplantation - The CO23 ANRS CUPILT study.
    J Hepatol. 2016 Jun 1. pii: S0168-8278(16)30253.
    PubMed     Text format     Abstract available


    May 2016
  11. BELLI LS, Berenguer M, Cortesi PA, Strazzabosco M, et al
    DELISTING OF LIVER TRANSPLANT CANDIDATES WITH CHRNIC HEPATITIC C AFTER VIRAL ERADICATION: A EUROPEAN STUDY.
    J Hepatol. 2016 May 17. pii: S0168-8278(16)30196.
    PubMed     Text format     Abstract available


  12. SCHLEGEL A, Kron P, de Oliveira ML, Clavien PA, et al
    Reply to 'Is single portal vein perfusion the best approach for machine preservation of liver grafts?'.
    J Hepatol. 2016;64:1195-6.
    PubMed     Text format    


  13. BRUGGENWIRTH IM, Burlage LC, Porte RJ, Martins PN, et al
    Is single portal vein perfusion the best approach for machine preservation of liver grafts?
    J Hepatol. 2016;64:1194-5.
    PubMed     Text format    


    April 2016
  14. WESTBROOK RH, Dusheiko G, Williamson C
    Pregnancy and liver disease.
    J Hepatol. 2016;64:933-45.
    PubMed     Text format     Abstract available


    January 2016
  15. EMOND JC, Zimmer TS
    Measuring access to liver transplantation: an overdue metric for center quality and performance.
    J Hepatol. 2016 Jan 28. pii: S0168-8278(16)00059.
    PubMed     Text format    


  16. SCHLEGEL A, Kron P, De Oliveira ML, Clavien PA, et al
    Is single portal vein approach sufficient for hypothermic machine perfusion of DCD liver grafts?
    J Hepatol. 2016;64:239-41.
    PubMed     Text format    


    November 2015
  17. HONG G, Suh KS, Suh S, Yoo T, et al
    Preoperative Alpha-fetoprotein and F-FDG PET Predict Tumor Recurrence better than Milan Criteria in Living Donor Liver Transplantation.
    J Hepatol. 2015 Nov 30. pii: S0168-8278(15)00791.
    PubMed     Text format     Abstract available


  18. GOLDBERG DS, French B, Lewis JD, Scott FI, et al
    Liver transplant center variability in accepting organ offers and its impact on patient survival.
    J Hepatol. 2015 Nov 25. pii: S0168-8278(15)00773.
    PubMed     Text format     Abstract available



  19. EASL Clinical Practice Guidelines: Liver transplantation.
    J Hepatol. 2015 Nov 17. pii: S0168-8278(15)00677.
    PubMed     Text format    


    September 2015
  20. COILLY A, Samuel D
    Pros and Cons: Usage of organs from donors infected with hepatitis C virus - revision in the direct acting antiviral era.
    J Hepatol. 2015 Sep 12. pii: S0168-8278(15)00617.
    PubMed     Text format     Abstract available


    August 2015
  21. GRANCINI V, Trombetta M, Lunati ME, Zimbalatti D, et al
    Contribution of beta-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: role of severity of liver disease.
    J Hepatol. 2015 Aug 19. pii: S0168-8278(15)00553.
    PubMed     Text format     Abstract available


  22. BOSCH A, Dumortier J, Maucort-Boulch D, Scoazec JY, et al
    Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence.
    J Hepatol. 2015 Aug 14. pii: S0168-8278(15)00545.
    PubMed     Text format     Abstract available


    July 2015
  23. MILTIADOUS O, Sia D, Hoshida Y, Fiel MI, et al
    Progenitor cell markers predict outcome of patients with Hepatocellular Carcinoma beyond Milan criteria undergoing liver transplantation.
    J Hepatol. 2015 Jul 25. pii: S0168-8278(15)00516.
    PubMed     Text format     Abstract available


  24. TODD STRAVITZ R, Reuben A, Mizrahi M, Lalazar G, et al
    Use of the Methacetin Breath Test to Classify the Risk of Cirrhotic Complications and Mortality in Patients Evaluated/Listed for Liver Transplantation.
    J Hepatol. 2015 Jul 25. pii: S0168-8278(15)00512.
    PubMed     Text format     Abstract available


  25. RAVIKUMAR R, Tsochatzis E, Jose S, Allison M, et al
    Risk Factors for Recurrent Primary Sclerosing Cholangitis After Liver Transplantation.
    J Hepatol. 2015 Jul 14. pii: S0168-8278(15)00467.
    PubMed     Text format     Abstract available


  26. YEOMAN AD, Kotha S, Heneghan MA
    Reply to "The role of corticosteroids in acute-severe autoimmune hepatitis is still highly debatable".
    J Hepatol. 2015 Jul 8. pii: S0168-8278(15)00457.
    PubMed     Text format    


    June 2015
  27. DE MARTIN E, Coilly A, Ichai P, Samuel D, et al
    The role of corticosteroids in acute-severe autoimmune hepatitis is still highly debatable.
    J Hepatol. 2015 Jun 30. pii: S0168-8278(15)00417.
    PubMed     Text format    


  28. KOKUDO T, Hasegawa K, Uldry E, Matsuyama Y, et al
    A new formula for calculating standard liver volume for living donor liver transplantation without using body weight.
    J Hepatol. 2015 Jun 6. pii: S0168-8278(15)00384.
    PubMed     Text format     Abstract available


    April 2015
  29. MATHURIN P, Bataller R
    Trends in the management and burden of alcoholic liver disease.
    J Hepatol. 2015;62.
    PubMed     Text format     Abstract available


  30. ADAMS DH, Sanchez-Fueyo A, Samuel D
    From immunosuppression to tolerance.
    J Hepatol. 2015;62.
    PubMed     Text format     Abstract available


  31. BRUIX J, Han KH, Gores G, Llovet JM, et al
    Liver cancer: Approaching a personalized care.
    J Hepatol. 2015;62.
    PubMed     Text format    


  32. BERNAL W, Lee WM, Wendon J, Larsen FS, et al
    Acute liver failure: A curable disease by 2024?
    J Hepatol. 2015;62.
    PubMed     Text format     Abstract available


  33. MANNS MP, Lohse AW, Vergani D
    Autoimmune hepatitis - Update 2015.
    J Hepatol. 2015;62.
    PubMed     Text format    


    March 2015
  34. KARIMIAN N, Weeder PD, Bomfati F, Gouw AS, et al
    Preservation Injury of the Distal Extrahepatic Bile Duct of Donor Livers Is Representative for Injury of the Intrahepatic Bile Ducts.
    J Hepatol. 2015 Mar 18. pii: S0168-8278(15)00193.
    PubMed     Text format    


  35. SCHLEGEL A, Dutkowski P, Clavien PA
    Reply to: "The rescue of DCD rodent livers grafts: is there HOPE?".
    J Hepatol. 2015;62:739-41.
    PubMed     Text format    


  36. KOPP WH, Wijermars LG, Ringers J, Braat AE, et al
    The rescue of DCD rodent livers grafts: is there HOPE?
    J Hepatol. 2015;62:739.
    PubMed     Text format    


    January 2015
  37. LI H, Xia Q, Zeng B, Li ST, et al
    Submassive hepatic necrosis distinguishes HBV-associated acute-on chronic liver failure from cirrhotic patients with acute decompensation.
    J Hepatol. 2015 Jan 31. pii: S0168-8278(15)00060.
    PubMed     Text format     Abstract available


  38. ALLARD MA, Sebagh M, Ruiz A, Guettier C, et al
    Does Pathological Response for Hepatocellular Carcinoma in Patients with Cirrhosis Predict Outcome after Liver Resection or Transplantation?
    J Hepatol. 2015 Jan 31. pii: S0168-8278(15)00054.
    PubMed     Text format     Abstract available


    December 2014
  39. MUSSO G, Tabibian JH, Charlton M
    Chronic kidney disease (CKD) and NAFLD: time for hepatologists for awareness and screening.
    J Hepatol. 2014 Dec 18. pii: S0168-8278(14)00931.
    PubMed     Text format    


  40. ALLEN AM, Ray Kim W, Heimbach JK, Rule AD, et al
    Reply to: Chronic Kidney Disease (CKD) and NAFLD: time for hepatologists for awareness and screening.
    J Hepatol. 2014 Dec 18. pii: S0168-8278(14)00940.
    PubMed     Text format    


  41. KLUGER MD, Salceda JA, Laurent A, Tayar C, et al
    Liver Resection For Hepatocellular Carcinoma in 313 Western Patients: Tumor Biology and Underlying Liver Rather than Tumor Size Drive Prognosis.
    J Hepatol. 2014 Dec 18. pii: S0168-8278(14)00939.
    PubMed     Text format     Abstract available


    November 2014
  42. LIN LT, Chung CY, Hsu WC, Chang SP, et al
    Saikosaponin b2 is a Naturally Occurring Terpenoid That Efficiently Inhibits Hepatitis C Virus Entry.
    J Hepatol. 2014 Nov 4. pii: S0168-8278(14)00807.
    PubMed     Text format     Abstract available


  43. GAMBATO M, Lens S, Navasa M, Forns X, et al
    Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation.
    J Hepatol. 2014;61.
    PubMed     Text format     Abstract available


    August 2014
  44. JOSHITA S, Umemura T, Ota M, Tanaka E, et al
    AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis.
    J Hepatol. 2014 Aug 21. pii: S0168-8278(14)00609.
    PubMed     Text format    


  45. TRIVEDI PJ, Bruns T, Li KK, Hirschfield GM, et al
    Reply to: "AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis"
    J Hepatol. 2014 Aug 21. pii: S0168-8278(14)00606.
    PubMed     Text format    


  46. MOBUS S, Yang D, Yuan Q, Ludtke TH, et al
    MicroRNA-199a-5p inhibition enhances the liver repopulation ability of human embryonic stem cell-derived hepatic cells.
    J Hepatol. 2014 Aug 15. pii: S0168-8278(14)00556.
    PubMed     Text format     Abstract available


  47. SANGFELT P, Sundin A, Wanders A, Rasmussen I, et al
    Monitoring Dominant Strictures in Primary Sclerosing Cholangitis with Brush Cytology and FDG-PET.
    J Hepatol. 2014 Aug 8. pii: S0168-8278(14)00536.
    PubMed     Text format     Abstract available


    July 2014
  48. WEILER-NORMANN C, Lohse AW
    Acute Autoimmune Hepatitis: many open questions.
    J Hepatol. 2014 Jul 3. pii: S0168-8278(14)00460.
    PubMed     Text format    


    May 2014
  49. YEOMAN AD, Westbrook RH, Zen Y, Bernal W, et al
    Prognosis of acute severe autoimmune hepatitis (AS-AIH): The role of corticosteroids in modifying outcome.
    J Hepatol. 2014 May 16. pii: S0168-8278(14)00362.
    PubMed     Text format     Abstract available


    April 2014
  50. DUTKOWSKI P, Schlegel A, de Oliveira M, Mullhaupt B, et al
    HOPE for human liver grafts obtained from donors after cardiac death.
    J Hepatol. 2014;60:765-72.
    PubMed     Text format     Abstract available


    March 2014
  51. KULIK L, Vouche M, Koppe S, Lewandowski RJ, et al
    Prospective Randomized Pilot Study of Y90 +/- Sorafenib as Bridge to Transplantation in Hepatocellular Carcinoma.
    J Hepatol. 2014 Mar 26. pii: S0168-8278(14)00204.
    PubMed     Text format     Abstract available


    January 2014
  52. PERARNAU JM, Gouge AL, Nicolas C, d'Alteroche L, et al
    Covered versus uncovered stents for Transjugular Intrahepatic Portosystemic Shunt: a randomized controlled trial.
    J Hepatol. 2014 Jan 27. pii: S0168-8278(14)00061.
    PubMed     Text format     Abstract available


    December 2013
  53. IRANMANESH P, Vazquez O, Terraz S, Majno P, et al
    Accurate computed tomography-based portal pressure assessment in patients with hepatocellular carcinoma.
    J Hepatol. 2013 Dec 19. pii: S0168-8278(13)00883.
    PubMed     Text format     Abstract available


  54. MATTER MS, Decaens T, Andersen JB, Thorgeirsson SS, et al
    Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends.
    J Hepatol. 2013 Dec 2. pii: S0168-8278(13)00833.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: